stella
beta
Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia — Stella
Recruiting
Back to B-cell Lymphoma Refractory trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Chinese PLA General Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov